Tag | Content |
---|
EnhancerAtlas ID | HS018-13050 |
Organism | Homo sapiens |
Tissue/cell | CD19+ |
Coordinate | chr2:136989400-136991450 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOXP1 | MA0481.2 | chr2:136989425-136989437 | AAGTAAACAGAC | + | 6.52 | FOXP2 | MA0593.1 | chr2:136989425-136989436 | AAGTAAACAGA | + | 6.32 | TCF7L2 | MA0523.1 | chr2:136990118-136990132 | CTCCTTTGATGTTG | - | 6.03 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_09631 | chr2:136989924-136991198 | CD14 | SE_10274 | chr2:136989439-136991168 | CD19_Primary | SE_11065 | chr2:136988630-136991386 | CD20 | SE_61425 | chr2:136945577-137039880 | Toledo | SE_62403 | chr2:136962507-137014815 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr2 | 136990465 | 136990600 | chr2 | 136989548 | 136989652 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I136232 | chr2 | 136990414 | 136990888 |
|
Enhancer Sequence | TGAAATTAAC AAAGTTTGGG AAGGAAAGTA AACAGACCCA GAGAGTAATA GAAAAGGCGA 60 ATGAAATGAA AGGGCTCTGG GGAGAAGAAA GTTTGGATCC AGTGATGTGT GGAAGATAGC 120 AGCACACACA ATGAAGCAAA ACGGGAGGAT CGGTGAGTTG GATGGATGCT GAAAACCAGC 180 CAAACTCCCC ACTTCCTCAG CCTCAGAGCT TGGAAGGAGC TTCTGCTGTG TTGGGAATTC 240 CTGTTGCCAG AACGTCATCT TCTAGGTGCA GCTCATCAGG ATGTTGTAAA TGGTTTCTTA 300 ACAAAATTAT TCTTGCTAAG AGAAAGGGAG AAAGAAAATG CTTTTGAGTT TATCCATGCA 360 AGAAGGTCAT CAAAAAATGG CGATCAGCCT GAACTTTTTT GCTGAACTAA GAGAGTTCCT 420 TTAGTCGTTT TTCATGAAGT TCACAGTGTG ATTTTTATTC TATTTTGTAG ATCATGTTTT 480 CCTGTGATCT ACAAGGTGAC ATACAGCTTT GATAAGGATG TGATCAGCAT TCTGGTTTAA 540 TAATTGGCAT ACAATGGGTT TTTTGGAATT GCATCATATG TCTTCAGTAT TATTATTTCT 600 TTGCTTGGGT GATTTATTCT CCTGGATTCT GAGAACACAA ATTGGGCTTT TAGAGTTAGC 660 AAGCTGAAAA ATGTTCGTTT TTAAACCTGT TACTCCATAA AGTCGGCTGT GCCCTGAGCT 720 CCTTTGATGT TGCTCAGTAG ACACTGAGAA CGTTTCAGAC AAATTCATTT TTAACTGCTC 780 ACGGAGGGCT TTGGATTATC ATCTAGTCAT TGTTCTAACC ATTGGGACAG ACCTTTGCTG 840 AACAATGTTG GATTAATCAG GCAGAACAGA GCTCGAATCT CCTCATTCCT TTTGTCTGTA 900 TGAACTGAGC CCTGGACTCA CAGCACGTAG AATTCTGGGG CTTAGGGAGC TTCTGCCTGT 960 GCTTTATTTT GTTGTTTTAT TCAATTAAAA ATTAATTTTA GTTTGTTCTC TTTCTCCTCC 1020 ATGGCTCAAA CTATTAAAGA TAGTTCTGAG GAAGGAAATG CAAAATAGCA AGAAATTGTT 1080 CTGCTTGCCA ATGGCCCAGG GCCTCTTGCT TTCTAGGTTA AAAGGACTGT TTGGGGGAAA 1140 TGAAGTTCTG TCTCTCTAAC GACACTGTTT AGTTTTGCAT CCTATTTTAG TTGGAGGGTG 1200 AAATGAACCA GATCTGTTTC TAGCCAGTCT GACTCTTTGA TTCCAGATTG GGGCATCTTC 1260 AACAGGGTTT TATATCCTGT TGGAATGCAA GGCTATTTTA AGAAATCCCT ATTGGATTGA 1320 GAAAAAGCAC ATAGTATAAT TATGGTGACC AAACCATGTG TCCCAGATTT TCCAGGATGT 1380 TCCCCAAATT CATGTAGTTT CAATCTTTTC AATAAAGTAA GTGCATTTTG TATGCATCAA 1440 CATGGAGCCT GATAAAGGGT ATCTTTGTGT ATGTGAGTGT GTAAAATAAA AATAAATATA 1500 TATAAGTATA TATATTTTAT ATAAATAAAA GTGTATATAC CCACTTTTTT GCTGTGTGTA 1560 TTCATTTAAA TGAAATCTTC TTTAGGATCT TGTGGTTTCA GAATAGATGA TCAGTAAGTA 1620 TTGCAAAAAT AACTGTCAAG GTCCTAACTA GCTGAGTGAC CTTGAACAAG TCAGTTCCTG 1680 TCTCTGGATC TCATCAGTTC CTCACCATTC TGGCACATAG CAGGATCTCA GTAACTGTGC 1740 TGTTGAAAAC CAAATGCCAA GCCCTTTCAG AATTCTCAGT CTTTGTCTTT ACTTCTCCCT 1800 CTGTGTGTTC CATACTCCAT GGCCTAGTCC ATTGTACTTG CCTCAGTCTT CATATTGTAT 1860 GATCTTTTAC TGTTGTCTTG TAAGCTTCAC TCCTAGGCTG CAAGAGGCTT GAGGGCTGGG 1920 ATGGGTCTTC ACATTTAAAA AATCTCCATG GTTTAGCACA GTGCCAGGCA GATATAAAAA 1980 AACAAACTGA AGGAAATACA CCAAAAAGAT GAGATAATAG ATGACAATAA AAATGTATTC 2040 TTCATACTTT 2050
|